JOINT CORP/THE (JYNT)
US47973J1025 - Common Stock
JYNT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 107 industry peers in the Health Care Providers & Services industry. While JYNT seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, JYNT is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
JYNT had negative earnings in the past year.
JYNT had a positive operating cash flow in the past year.
JYNT had positive earnings in 4 of the past 5 years.
In the past 5 years JYNT always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of -21.18%, JYNT is doing worse than 80.95% of the companies in the same industry.
JYNT's Return On Equity of -82.42% is on the low side compared to the rest of the industry. JYNT is outperformed by 75.24% of its industry peers.
JYNT has a Return On Invested Capital (2.64%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for JYNT is below the industry average of 8.15%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -21.18% | ||
| ROE | -82.42% | ||
| ROIC | 2.64% |
ROA(3y)-0.61%
ROA(5y)5.15%
ROE(3y)-4.16%
ROE(5y)21.54%
ROIC(3y)3.17%
ROIC(5y)5.54%
1.3 Margins
With a Operating Margin value of 1.14%, JYNT perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
In the last couple of years the Operating Margin of JYNT has declined.
JYNT's Gross Margin of 90.70% is amongst the best of the industry. JYNT outperforms 98.10% of its industry peers.
In the last couple of years the Gross Margin of JYNT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.14% | ||
| PM (TTM) | N/A | ||
| GM | 90.7% |
OM growth 3Y-62.75%
OM growth 5Y-26.26%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.79%
GM growth 5Y0.62%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), JYNT is destroying value.
JYNT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, JYNT has more shares outstanding
JYNT has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.96 indicates that JYNT is not a great score, but indicates only limited risk for bankruptcy at the moment.
JYNT's Altman-Z score of 2.96 is fine compared to the rest of the industry. JYNT outperforms 70.48% of its industry peers.
JYNT has a debt to FCF ratio of 0.01. This is a very positive value and a sign of high solvency as it would only need 0.01 years to pay back of all of its debts.
JYNT's Debt to FCF ratio of 0.01 is amongst the best of the industry. JYNT outperforms 92.38% of its industry peers.
JYNT has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
JYNT has a better Debt to Equity ratio (0.00) than 85.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.01 | ||
| Altman-Z | 2.96 |
ROIC/WACC0.29
WACC9.18%
2.3 Liquidity
A Current Ratio of 1.44 indicates that JYNT should not have too much problems paying its short term obligations.
With a Current ratio value of 1.44, JYNT perfoms like the industry average, outperforming 51.43% of the companies in the same industry.
A Quick Ratio of 1.44 indicates that JYNT should not have too much problems paying its short term obligations.
The Quick ratio of JYNT (1.44) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.44 |
3. Growth
3.1 Past
JYNT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -892.31%.
The Revenue has been growing slightly by 5.75% in the past year.
Measured over the past years, JYNT shows a very strong growth in Revenue. The Revenue has been growing by 26.25% on average per year.
EPS 1Y (TTM)-892.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-320%
Revenue 1Y (TTM)5.75%
Revenue growth 3Y26.1%
Revenue growth 5Y26.25%
Sales Q2Q%2.46%
3.2 Future
JYNT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 43.05% yearly.
JYNT is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -9.16% yearly.
EPS Next Y42.2%
EPS Next 2Y56.86%
EPS Next 3Y43.05%
EPS Next 5YN/A
Revenue Next Year2.57%
Revenue Next 2Y-5.56%
Revenue Next 3Y-9.16%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
JYNT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
JYNT is valuated quite expensively with a Price/Forward Earnings ratio of 35.00.
Compared to the rest of the industry, the Price/Forward Earnings ratio of JYNT is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of JYNT to the average of the S&P500 Index (23.69), we can say JYNT is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 35 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as JYNT.
69.52% of the companies in the same industry are more expensive than JYNT, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.14 | ||
| EV/EBITDA | 19.16 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as JYNT's earnings are expected to grow with 43.05% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y56.86%
EPS Next 3Y43.05%
5. Dividend
5.1 Amount
JYNT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
JOINT CORP/THE
NASDAQ:JYNT (1/3/2025, 8:00:02 PM)
After market: 10.64 0 (0%)10.64
+0.21 (+2.01%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners73.57%
Inst Owner Change-1.64%
Ins Owners1.53%
Ins Owner Change2.02%
Market Cap159.39M
Analysts78.18
Price Target16.7 (56.95%)
Short Float %3.19%
Short Ratio10.13
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1644.77%
Min EPS beat(2)-2673.53%
Max EPS beat(2)-616.02%
EPS beat(4)1
Avg EPS beat(4)-2109.15%
Min EPS beat(4)-6227.45%
Max EPS beat(4)1080.39%
EPS beat(8)2
Avg EPS beat(8)-812.96%
EPS beat(12)3
Avg EPS beat(12)-559.07%
EPS beat(16)7
Avg EPS beat(16)-354.13%
Revenue beat(2)2
Avg Revenue beat(2)2.63%
Min Revenue beat(2)0.92%
Max Revenue beat(2)4.33%
Revenue beat(4)3
Avg Revenue beat(4)1.73%
Min Revenue beat(4)-1.53%
Max Revenue beat(4)4.33%
Revenue beat(8)3
Avg Revenue beat(8)-0.15%
Revenue beat(12)5
Avg Revenue beat(12)-0.65%
Revenue beat(16)9
Avg Revenue beat(16)0.58%
PT rev (1m)0%
PT rev (3m)-1.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-64.03%
EPS NY rev (1m)0%
EPS NY rev (3m)-196.82%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)6.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.56%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 35 | ||
| P/S | 1.32 | ||
| P/FCF | 24.14 | ||
| P/OCF | 18.38 | ||
| P/B | 7.79 | ||
| P/tB | 9.83 | ||
| EV/EBITDA | 19.16 |
EPS(TTM)-1.03
EYN/A
EPS(NY)0.3
Fwd EY2.86%
FCF(TTM)0.44
FCFY4.14%
OCF(TTM)0.58
OCFY5.44%
SpS8.06
BVpS1.37
TBVpS1.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -21.18% | ||
| ROE | -82.42% | ||
| ROCE | 3.34% | ||
| ROIC | 2.64% | ||
| ROICexc | 5.3% | ||
| ROICexgc | 6.67% | ||
| OM | 1.14% | ||
| PM (TTM) | N/A | ||
| GM | 90.7% | ||
| FCFM | 5.47% |
ROA(3y)-0.61%
ROA(5y)5.15%
ROE(3y)-4.16%
ROE(5y)21.54%
ROIC(3y)3.17%
ROIC(5y)5.54%
ROICexc(3y)4.42%
ROICexc(5y)8.38%
ROICexgc(3y)5.83%
ROICexgc(5y)11.77%
ROCE(3y)4.02%
ROCE(5y)7.01%
ROICexcg growth 3Y-55.68%
ROICexcg growth 5YN/A
ROICexc growth 3Y-57.16%
ROICexc growth 5Y-38.54%
OM growth 3Y-62.75%
OM growth 5Y-26.26%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.79%
GM growth 5Y0.62%
F-Score5
Asset Turnover1.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.01 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 35.34% | ||
| Cap/Sales | 1.71% | ||
| Interest Coverage | 19.78 | ||
| Cash Conversion | 119.81% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.44 | ||
| Altman-Z | 2.96 |
F-Score5
WACC9.18%
ROIC/WACC0.29
Cap/Depr(3y)108.43%
Cap/Depr(5y)124.84%
Cap/Sales(3y)6.27%
Cap/Sales(5y)6.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-892.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-320%
EPS Next Y42.2%
EPS Next 2Y56.86%
EPS Next 3Y43.05%
EPS Next 5YN/A
Revenue 1Y (TTM)5.75%
Revenue growth 3Y26.1%
Revenue growth 5Y26.25%
Sales Q2Q%2.46%
Revenue Next Year2.57%
Revenue Next 2Y-5.56%
Revenue Next 3Y-9.16%
Revenue Next 5YN/A
EBIT growth 1Y288.98%
EBIT growth 3Y-53.03%
EBIT growth 5Y-6.9%
EBIT Next Year671.87%
EBIT Next 3Y125.51%
EBIT Next 5YN/A
FCF growth 1Y537.22%
FCF growth 3Y6.47%
FCF growth 5Y17.4%
OCF growth 1Y96.21%
OCF growth 3Y9.5%
OCF growth 5Y21.91%